Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/4/2025

Antiemetic Management in Pheochromocytoma

Safe Antiemetic Options

  • The American Society of Clinical Oncology recommends 5-HT3 receptor antagonists (ondansetron, granisetron, palonosetron) as the safest first-line options for patients with confirmed or suspected pheochromocytoma requiring antiemetics 2, 3
  • The National Comprehensive Cancer Network suggests ondansetron: 8 mg oral or IV every 8-12 hours 3
  • The National Comprehensive Cancer Network recommends granisetron: 1-2 mg oral or 1 mg IV 3
  • The National Comprehensive Cancer Network advises palonosetron: 0.5 mg oral or 0.25 mg IV 3
  • Phenothiazines (prochlorperazine, promethazine) may be used cautiously, as they are included in standard antiemetic protocols without specific pheochromocytoma warnings, with prochlorperazine: 10 mg oral/IV every 6 hours as needed 1
  • Benzodiazepines (lorazepam) are safe adjuncts for anticipatory nausea and anxiety-related symptoms, with lorazepam: 1 mg oral every 1-2 hours as needed 1, 2

Emergency Management if Crisis Occurs

  • The American Heart Association recommends phentolamine (alpha-blocker) as the specific antidote for catecholamine-induced hypertensive crisis 4
  • Alternative agents include clevidipine, nicardipine, or nitroprusside for rapid blood pressure control 5
  • The American Heart Association advises never to use beta-blockers alone without prior alpha-blockade, as unopposed alpha-stimulation can worsen hypertension 4

Clinical Context

  • Pheochromocytoma represents 0.1-0.6% of hypertensive patients but up to 23% of resistant hypertension cases, with an average 3-year delay between symptoms and diagnosis 7
  • The diagnosis is often missed, with 75% of cases not suspected before autopsy, and classic triad of headaches, palpitations, and sweating occurring episodically has 90% diagnostic specificity 7
  • Plasma free metanephrines have 99% sensitivity for diagnosis 7